2947 - 2954 |
Purification of recombinant protein by cold-coacervation of fusion constructs incorporating resilin-inspired polypeptides Lyons RE, Elvin CM, Taylor K, Lekieffre N, Ramshaw JAM |
2955 - 2961 |
Design of Ca2+-independent Staphylococcus aureus sortase A mutants Hirakawa H, Ishikawa S, Nagamune T |
2962 - 2969 |
Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens Welsh JP, Lu Y, He XS, Greenberg HB, Swartz JR |
2970 - 2977 |
A novel technique for in situ aggregation of Gluconobacter oxydans using bio-adhesive magnetic nanoparticles Ni KF, Lu HM, Wang CX, Black KCL, Wei DZ, Ren YH, Messersmith PB |
2978 - 2986 |
Development of chimeric laccases by directed evolution Pardo I, Vicente AI, Mate DM, Alcalde M, Camarero S |
2987 - 2996 |
Growth kinetics of microalgae in microfluidic static droplet arrays Dewan A, Kim J, McLean RH, Vanapalli SA, Karim MN |
2997 - 3006 |
A new dynamic model for highly efficient mass transfer in aerated bioreactors and consequences for kLa identification Muller S, Murray DB, Machne R |
3007 - 3017 |
The characterization and quantitation of glycomic changes in CHO cells during a bioreactor campaign Tep S, Hincapie M, Hancock WS |
3018 - 3029 |
Integrated continuous production of recombinant therapeutic proteins Warikoo V, Godawat R, Brower K, Jain S, Cummings D, Simons E, Johnson T, Walther J, Yu M, Wright B, McLarty J, Karey KP, Hwang C, Zhou WC, Riske F, Konstantinov K |
3030 - 3040 |
Photobioreactor design for isotopic non-stationary 13C-metabolic flux analysis (INST 13C-MFA) under photoautotrophic conditions Martzolff A, Cahoreau E, Cogne G, Peyriga L, Portais JC, Dechandol E, Le Grand F, Massou S, Goncalves O, Pruvost J, Legrand J |
3041 - 3048 |
Biodefluorination and biotransformation of fluorotelomer alcohols by two alkane-degrading Pseudomonas strains Kim MH, Wang N, McDonald T, Chu KH |
3049 - 3058 |
A new large-scale manufacturing platform for complex biopharmaceuticals Vogel JH, Nguyen H, Giovannini R, Ignowski J, Garger S, Salgotra A, Tom J |
3059 - 3069 |
Implementation of proton transfer reaction-mass spectrometry (PTR-MS) for advanced bioprocess monitoring Luchner M, Gutmann R, Bayer K, Dunkl J, Hansel A, Herbig J, Singer W, Strobl F, Winkler K, Striedner G |
3070 - 3083 |
Multi-dimensional fractionation and characterization of crude protein mixtures: Toward establishment of a database of protein purification process development parameters Nfor BK, Ahamed T, Pinkse MWH, van der Wielen LAM, Verhaert PDEM, van Dedem GWK, Eppink MHM, van de Sandt EJAX, Ottens M |
3084 - 3092 |
Recovery modeling of tangential flow systems Rao S, Gefroh E, Kaltenbrunner O |
3093 - 3102 |
Rapamycin treatment inhibits CHO cell death in a serum-free suspension culture by autophagy induction Lee JS, Lee GM |
3103 - 3111 |
LC-MS-based metabolic characterization of high monoclonal antibody-producing Chinese hamster ovary cells Chong WPK, Thng SH, Hiu AP, Lee DY, Chan ECY, Ho YS |
3112 - 3118 |
Detection of cellular response to titanium dioxide nanoparticle agglomerates by sensor cells using heat shock protein promoter Chen P, Kanehira K, Sonezaki S, Taniguchi A |
3119 - 3132 |
Confined 3D microenvironment regulates early differentiation in human pluripotent stem cells Giobbe GG, Zagallo M, Riello M, Serena E, Masi G, Barzon L, Di Camillo B, Elvassore N |
3133 - 3142 |
Global regulator engineering significantly improved Escherichia coli tolerances toward inhibitors of lignocellulosic hydrolysates Wang JQ, Zhang Y, Chen YL, Lin M, Lin ZL |
3143 - 3151 |
An improved bioluminescence-based signaling assay for odor sensing with a yeast expressing a chimeric olfactory receptor Fukutani Y, Ishii J, Noguchi K, Kondo A, Yohda M |
3152 - 3160 |
Scaffold-free inkjet printing of three-dimensional zigzag cellular tubes Xu CX, Chai WX, Huang Y, Markwald RR |
3161 - 3171 |
Visualizing feasible operating ranges within tissue engineering systems using a "windows of operation" approach: A perfusion-scaffold bioreactor case study McCoy RJ, O'Brien FJ |
3172 - 3181 |
Analysis of drug metabolism activities in a miniaturized liver cell bioreactor for use in pharmacological studies Hoffmann SA, Muller-Vieira U, Biemel K, Knobeloch D, Heydel S, Lubberstedt M, Nussler AK, Andersson TB, Gerlach JC, Zeilinger K |
3182 - 3188 |
Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver Nibourg GAA, Boer JD, van der Hoeven TV, Ackermans MT, van Gulik TM, Chamuleau RAFM, Hoekstra R |
3189 - 3198 |
Design and validation of a corneal bioreactor Leonard EK, Pai VH, Amberg P, Gardner J, Orwin EJ |
3199 - 3204 |
An amperometric enzyme biosensor for real-time measurements of cellobiohydrolase activity on insoluble cellulose Cruys-Bagger N, Ren GL, Tatsumi H, Baumann MJ, Spodsberg N, Andersen HD, Gorton L, Borch K, Westh P |